ArticleJournal for immunotherapy of cancer2020

Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells.

Yuichi Iida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.